R-Biopharm

What R-Biopharm does

R-Biopharm AG is a privately held German biotechnology company founded in 1988, headquartered in Darmstadt with corporate seat in Pfungstadt. The company develops diagnostic test solutions across three divisions: Clinical Diagnostics (multiplex molecular biology assays via AusDiagnostics, immunoassays), Food & Feed Analysis (lateral flow tests such as RIDA®QUICK for mycotoxin and allergen detection, ELISA kits, microbiological and GMO testing), and Nutrition Care (programs for wellbeing, prevention, and therapy via nutrition-care.de). Underlying technology spans ELISA immunoassays, lateral flow immunochromatography, multiplex molecular diagnostics, and the RIDA®SMART APP, a smartphone-based computer vision tool using a patented algorithm to quantify lateral flow test results in the field.

R-Biopharm serves a strictly B2B customer base — the company explicitly states it does not supply consumers — through a sales-led motion combining a direct e-commerce webshop (shop.r-biopharm.com), authorized distributors registered via a portal, and regional subsidiaries including R-Biopharm Rhône Ltd. in Scotland, which develops and manufactures test kits and has achieved PAS 2060:2014 carbon neutrality verified by BSI. The product portfolio exceeds 500 SKUs distributed across 140+ countries; equipment rental is tied exclusively to R-Biopharm consumables, and software requires license-key registration with internet verification.

Revenue is generated through one-time product sales (kits, reagents), recurring equipment rental/loan, software licensing, and professional services including sample testing and technical support. Pricing is not publicly disclosed; orders operate on 30-day payment terms, with regional shipping thresholds. The company is family-controlled (CEO Christian Dreher, Supervisory Board Chairman Dr. Ralf M. Dreher), ISO 9001 and ISO 13485 certified, and pursues ISO 14001 environmental management certification at headquarters.

Name

R-Biopharm

Legal name

R-Biopharm AG

Website

https://r-biopharm.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

R-Biopharm AG is a German biotech company developing diagnostic test kits, reagents, and mobile-analysis software for clinical diagnostics, food and feed safety, and nutrition care, serving B2B customers across 140+ countries via direct webshop, distributors, and subsidiaries.

Ownership category

akta.pro rank

Product category

Clinical Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Food, Feed & Nutraceutical Analytical Testing (HLAGADAN)

akta.pro secondary industries

Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Proficiency Testing, Method Validation & Reference Materials (Food Labs) (AFALAAAK), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Diagnostic test kits
• Food safety analysis
• Clinical diagnostics
• Mycotoxin testing
• Immunoassay reagents

Headquarters

HQ city

Darmstadt

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic and Testing Products: Sale of test kits, reagents, and diagnostic products for clinical diagnostics and food/feed analysis. Products include RIDA®QUICK lateral flow tests, ELISA kits, and related consumables. Orders placed via webshop, mail, phone, or email with payment terms of 30 days.
2. Laboratory Equipment Rental and Loan: Rental and loan of laboratory equipment subject to supplemental terms (Rental and Loan Conditions). Equipment provided exclusively for use with R-Biopharm products.
3. Software Licenses and SaaS: Software products including RIDA®SMART APP with license key registration and internet connection requirement for license verification. Software support services vary by product and business relationship.
4. Professional Services: Services including sample testing, claim assessment, device maintenance, and technical support. Subject to separate General Service Conditions.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

R-Biopharm develops, manufactures, and sells diagnostic test kits, reagents, and analytical instruments for clinical diagnostics and food/feed safety testing. Core products include RIDA®QUICK lateral flow tests for mycotoxin detection, ELISA kits for proteins and allergens, the RIDA®SMART APP for smartphone-based test evaluation, and AusDiagnostics multiplex molecular diagnostics. The company also offers laboratory equipment, consumables, and professional services such as sample testing and technical support.

Differentiator

Problem solved

Functional benefit

Brands

• RIDA®SMART APP: A digital application for the quantification of RIDA®QUICK Mycotoxin Lateral Flow Tests, enabling fast and reliable quality control for mycotoxin contamination detection in food, feed, and raw materials.
• Clinical Diagnostics
• Food & Feed Analysis
• Nutrition Care

Products and services

• RIDA®QUICK Lateral Flow Tests Rapid lateral flow immunoassay kits designed for the qualitative and quantitative detection of mycotoxins in food and feed samples; intended for use by food and feed quality control laboratories and on-site operators, often paired with the RIDA®SMART APP for smartphone-based readout.
• ELISA Test Kits Enzyme-linked immunosorbent assay kits for the detection of proteins, allergens, mycotoxins, hormones, antibiotics, and other analytes in food, feed, and clinical samples; targeted at commercial testing laboratories and clinical labs performing routine batch analysis.
• RIDA®SMART APP Smartphone application using a patented algorithm to evaluate RIDA®QUICK lateral flow tests, providing quantitative results without specialized laboratory readers; for food and feed producers, processors, and field inspectors performing on-site mycotoxin screening.
• AusDiagnostics Multiplex Molecular Diagnostics Platform Multiplex molecular diagnostic assays and instruments (via subsidiary AusDiagnostics) enabling simultaneous detection of multiple pathogens or targets in clinical and applied diagnostics; for hospital and reference laboratories running high-throughput molecular testing.
• Laboratory Equipment (incl. rental/loan) Laboratory instruments, readers, and consumables available for purchase or rental/loan to support R-Biopharm's immunoassay and molecular diagnostic workflows; intended for commercial and clinical laboratory customers.
• Professional Services (Sample Testing & Technical Support) Analytical services and technical support including sample testing and customer technical assistance; offered to food/feed producers, processors, and clinical laboratory customers using or evaluating R-Biopharm diagnostic products.

Quantifiable outcome

• Reduced carbon footprint by approximately 29% in 2022 through renewable electricity and energy-saving initiatives
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• AusDiagnosticscoreStrategic or Co-development Partner · 7 June 2022R-Biopharm AG acquired Australian molecular biology diagnostics company AusDiagnostics in June 2022. The acquisition expands R-Biopharm's product portfolio and market presence in clinical diagnostics, leveraging AusDiagnostics' multiplex analysis platform used globally in hospitals and laboratories. The deal strengthens R-Biopharm's position as a provider of system solutions in laboratory diagnostics.
• Custom MedicalminorStrategic or Co-development PartnerR-Biopharm collaborated with experts from Custom Medical in Darmstadt to analyze user needs, examine pain points during use, and jointly optimize the user experience for the RIDA®SMART APP rapid mycotoxin analysis solution.
• LORICA GmbHminorImplementation/ SI/ Consulting PartnerLORICA GmbH (Pfotenhauerstr. 63, 01307 Dresden) operates the whistleblowing reporting system on behalf of R-Biopharm AG. LORICA acts as a processor for R-Biopharm AG, handling investigation of reported matters and follow-up actions.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad is a global clinical diagnostics and life science research company offering a broad test kit and reagent portfolio (including food safety pathogen testing) that directly competes with R-Biopharm's clinical diagnostics and food/feed analysis product lines.
• Romer Labs: Romer Labs specializes in mycotoxin, allergen, and food safety diagnostic test kits and reference materials. It is a focused, direct competitor to R-Biopharm in the mycotoxin and food/feed analysis segment, including lateral flow and ELISA formats.
• Hygiena: Hygiena provides rapid food safety and environmental hygiene diagnostic tests, including ATP and molecular pathogen detection. It competes with R-Biopharm's food/feed analysis product line in rapid on-site and laboratory food safety testing.
• bioMérieux: bioMérieux is a leading in vitro diagnostics and microbiology company serving both clinical diagnostics and industrial microbiology (including food safety). Its immunoassay, molecular, and culture-based food pathogen testing directly overlap with R-Biopharm's lateral flow, ELISA, and molecular offerings.
• Neogen Corporation: Neogen is a pure-play food safety and animal safety diagnostics company offering lateral flow, ELISA, and molecular test kits for mycotoxins, allergens, and pathogens—directly comparable to R-Biopharm's Food & Feed Analysis portfolio, including mycotoxin testing.

Broad incumbents

• Bureau Veritas: Bureau Veritas is a global TIC company with significant agri-food and commodity testing operations. It is a broad incumbent that competes with R-Biopharm for food and feed safety testing demand from producers, traders, and regulators worldwide.
• SGS (Société Générale de Surveillance): SGS is one of the world's largest testing, inspection, and certification companies with a major food and agricultural testing business. As a broad incumbent TIC provider, it competes with R-Biopharm in the food/feed safety value chain, particularly through contracted laboratory services.
• Eurofins Scientific: Eurofins is the world's largest food testing services network and also offers diagnostic test kits, making it a broad incumbent competitor. While R-Biopharm is more product-focused, both compete for food/feed safety testing spend from the same end-customers (food producers, feed mills, regulators).
• Charles River Laboratories: Charles River provides laboratory and diagnostic services across life sciences, food safety, and clinical research. It is a broad incumbent serving overlapping end-markets (food, feed, clinical) with bundled testing and product offerings adjacent to R-Biopharm's portfolio.
• Euroimmun (Revvity/PerkinElmer): Euroimmun is a leading European autoimmune and infectious disease diagnostics company, now part of Revvity (formerly PerkinElmer). Its specialty IVD and immunoassay portfolio competes with R-Biopharm's clinical diagnostics division, including the AusDiagnostics multiplex platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rbiopharm
• YouTubeyoutube.com/channel/UCS452KmjcExwfpKTnc3obIA
• LinkedInlinkedin.com/company/r-biopharm-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about R-Biopharm